The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Forest Laboratories's revenues will decrease -23.7% and EPS will contract -76.9%.
The average estimate for revenue is $805.0 million. On the bottom line, the average EPS estimate is $0.18.
Last quarter, Forest Laboratories chalked up revenue of $722.7 million. GAAP reported sales were 40% lower than the prior-year quarter's $1.20 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at -$0.21. GAAP EPS were -$0.58 for Q3 against $1.04 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 78.6%, 60 basis points better than the prior-year quarter. Operating margin was -26.6%, much worse than the prior-year quarter. Net margin was -21.4%, much worse than the prior-year quarter.
The full year's average estimate for revenue is $3.09 billion. The average EPS estimate is $0.40.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Forest Laboratories is outperform, with an average price target of $37.45.
- Add Forest Laboratories to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.